Ohio-ACC Spring Summit 4/29/15

www.ohioacc.org

Register Now |  Interactive Brochure |  pdf Brochure | Exhibitor info  |  Mobile Event App

Spring Summit:

8th Annual CCA Cardiovascular Update &
52nd Annual Carl J. Wiggers Memorial Lecture

April 29, 2015 | The Ritz-Carlton, Cleveland

You can register online.

Meeting Location

The Ritz-Carlton, Cleveland

1515 West Third Street

Cleveland,Ohio44113

(216) 623-1300

Cancellations

Cancellation requests must be received by Wednesday, April 22, 2015. No refunds will be made after that date.

Statement of Need

Cardiovascular disease is the leading health care problem throughout the world.  In theUnited States alone, an estimated 70 million people have been diagnosed with one or more forms of cardiovascular disease (CV), and over 910,000 Americans die from CV disease each year. The cardiac care team is increasingly asked to develop systems of care, the methods for which are not necessarily part of the traditional medical training. We are asked to do this better, faster, more efficiently and at a lower cost.

Overall Goal

Physicians and cardiac care associates are required to maintain up-to-date knowledge of the latest clinical developments in the practice of cardiology to improve patient outcomes. The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in team based patient care practice as new clinical approaches and technologies change. Physicians and cardiac care associates are required to maintain up-to-date knowledge of the latest clinical developments in the practice of cardiology to improve patient outcomes. The Ohio Chapter-ACC Spring Summit will include education that provides needs-based learning covering a thorough overview of important cardiovascular updates.

Learner Objectives

Upon completion of this program, participants should be able to:

  • Discuss the newer available therapies for aortic valve disease, including TAVR, and appropriately refer patients for these treatments.
  • Compare and contrast the most current interventional treatment strategies for atrial fibrillation.
  • Address and apply the guidelines and the treatment options available for the heart failure patient to minimize re-admissions.
  • Review the literature and guidelines on the use of statin therapy.
  • Integrate the evidence-based research to make appropriate therapeutic decisions to treat patients with hypertrophic cardiomyopathy while discussing the role of ICDs in the prevention of sudden cardiac death.

Target Audience

Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Internal Medicine Physicians, Private Practice Physicians, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

ACCF Disclosure & COI Policy Statement

ACCF/Chapter committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all real or apparent conflicts of interest. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Full disclosure will be published in the syllabus.